Figure 2S.

Time-course studies with AMD3100 on BCC viability. BCCs cultured in the presence or absence of MSCs were treated for various times with a fixed dose of AMD3100, or untreated. At the appropriate endpoint, viability was assessed. Results are presented as the mean ± SD, na=3. *P≤0.05 vs. BCC alone